We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$244B
AUM Growth
-$56.4B
Cap. Flow
-$3.82B
Cap. Flow %
-1.57%
Top 10 Hldgs %
13.08%
Holding
11,816
New
1,263
Increased
3,667
Reduced
5,053
Closed
1,052

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$641M
2
MSFT icon
Microsoft
MSFT
+$477M
3
ACN icon
Accenture
ACN
+$354M
4
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$332M
5
CVX icon
Chevron
CVX
+$304M

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.94%
2 Technology 11.68%
3 Healthcare 7.04%
4 Financials 6.98%
5 Consumer Discretionary 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHE
10176
Alterity Therapeutics
ATHE
$68.3M
-1,049
Closed -$9K
ETHZW
10177
DELISTED
ETHZilla Corp Warrant
ETHZW
-2,021
Closed -$1K
ATNM icon
10178
Actinium Pharmaceuticals
ATNM
$37.4M
$0 ﹤0.01%
+36
New +$204
ATRO icon
10179
Astronics
ATRO
$2.79B
-5,263
Closed -$57K
ATXS
10180
DELISTED
Astria Therapeutics
ATXS
$0 ﹤0.01%
+25
New +$112
AU icon
10181
CALL
AngloGold Ashanti
AU
$51.8B
-321,200
Closed -$7.61M
AUPH icon
10182
CALL
Aurinia Pharmaceuticals
AUPH
$2.26B
-29,600
Closed -$366K
AUSF icon
10183
Global X Adaptive US Factor ETF
AUSF
$904M
-1,200
Closed -$38K
AVD icon
10184
American Vanguard Corp
AVD
$64.3M
-2,792
Closed -$57K
AVDE icon
10185
Avantis International Equity ETF
AVDE
$19.1B
-106
Closed -$6K
AVRE icon
10186
Avantis Real Estate ETF
AVRE
$860M
-133
Closed -$7K
AVSF icon
10187
Avantis Short-Term Fixed Income ETF
AVSF
$652M
-2,231
Closed -$106K
AVUS icon
10188
Avantis US Equity ETF
AVUS
$14.4B
$0 ﹤0.01%
3
AZEK
10189
CALL
DELISTED
The AZEK Co
AZEK
-40,000
Closed -$994K
AZN icon
10190
CALL
AstraZeneca
AZN
$258B
-64,800
Closed -$8.6M
AZTA icon
10191
CALL
Azenta
AZTA
$1.47B
-62,800
Closed -$5.21M
BARK icon
10192
BARK
BARK
$80.8M
$0 ﹤0.01%
16
-1,944
-99% -$98K
BBAI icon
10193
PUT
BigBear.ai
BBAI
$1.36B
-75,400
Closed -$621K
BBAI.WS icon
10194
BigBear.ai Holdings Warrant
BBAI.WS
$18.2M
-19,918
Closed -$18K
BBD icon
10195
PUT
Banco Bradesco
BBD
$36.8B
-53,240
Closed -$225K
BBHY icon
10196
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$621M
-1,263
Closed -$62K
BDX icon
10197
CALL
Becton Dickinson
BDX
$49.4B
-26,138
Closed -$6.61M
BEAT icon
10198
Heartbeam
BEAT
$23.6M
-632
Closed -$1K
BELFB
10199
Bel Fuse Inc Class B
BELFB
$3.44B
$0 ﹤0.01%
6
-2,047
-100% -$33.3K
BEN icon
10200
CALL
Franklin Templeton
BEN
$16.8B
-500
Closed -$14K

Similar funds

UBS Group's Q2 2022 Portfolio in Review

As of Q2 2022, UBS Group held 11,816 positions worth $244B, down 19% from $300B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2022 filing shows 1,263 new, 3,667 increased, 5,053 reduced and 1,052 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 137,765 shares worth $13.8M. The largest sale was Apple, an estimated $641M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 50% a quarter earlier, followed by Technology and Healthcare.

  • UBS Group's largest Q2 2022 buy was iShares 0-3 Month Treasury Bond ETF: 137,765 shares worth $13.8M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $453M increase.
  • UBS Group's biggest Q2 2022 reduction was Apple, cutting an estimated $641M.
  • UBS Group fully exited Cerner Corp in Q2 2022, selling an estimated $177M.
  • UBS Group's ten largest holdings make up 13% of its $244B portfolio in Q2 2022.
  • UBS Group opened 1,263 new positions and closed 1,052 in Q2 2022.
  • UBS Group's portfolio value fell 19% quarter-over-quarter to $244B.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.